1,200
Participants
Start Date
October 21, 2020
Primary Completion Date
April 1, 2025
Study Completion Date
April 1, 2025
Blood tests for Single Nucleotide Polymorphisms
This extra test would be performed on participants assessed in the specialist liver clinic. This test would require an extra 5ml of blood to be taken at the time of routine blood tests for clinical purposes.
Faecal microbiome analysis
This test will be undertaken for all participants who give consent and are assessed through the new liver care pathway, in the community liver assessment clinic. All participants will be given the equipment to take a stool sample at the time of presentation at the community liver assessment clinic and asked to return the sample to the clinic. The sample will be processed to remove genetic material so the microbiome can be identified.
Serum for diagnostic biomarkers
Blood samples will be taken alongside blood taken for clinical assessment. In total, an extra 5ml of blood. These samples will be used to explore novel blood biomarkers using ELISA and mass-spectroscopy techniques in the University of Manchester.
RECRUITING
Manchester University NHS Foundation Trust, Manchester
Collaborators (1)
University of Manchester
OTHER
University of Nottingham
OTHER
Innovate UK
OTHER_GOV
Manchester University NHS Foundation Trust
OTHER_GOV